Pulmonx Corporation - Common Stock (NQ:LUNG)

1.690 +0.130 (+8.33%)

Streaming Delayed Price Updated: 1:38 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulmonx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

September 09, 2022

From Pulmonx Corporation

Via Business Wire

Pulmonx to Present at Upcoming September Investor Conferences

August 24, 2022

From Pulmonx Corporation

Via Business Wire

Where Pulmonx Stands With Analysts ↗

August 03, 2022

Within the last quarter, Pulmonx (NASDAQ:LUNG) has observed the following analyst ratings:

Via Benzinga

Pulmonx: Q2 Earnings Insights ↗

August 02, 2022

Pulmonx (NASDAQ:LUNG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Pulmonx beat estimated earnings by...

Via Benzinga

Earnings Preview: Pulmonx ↗

August 01, 2022

Pulmonx (NASDAQ:LUNG) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Pulmonx will report...

Via Benzinga

Recap: Pulmonx Q4 Earnings ↗

February 23, 2022

Pulmonx (NASDAQ:LUNG) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Pulmonx...

Via Benzinga

Earnings Scheduled For November 2, 2021 ↗

November 02, 2021

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference

July 27, 2022

From Pulmonx Corporation

Via Business Wire

Pulmonx to Report Second Quarter 2022 Financial Results on August 2, 2022

July 19, 2022

From Pulmonx Corporation

Via Business Wire

Pulmonx: Q1 Earnings Insights ↗

May 03, 2022

Pulmonx (NASDAQ:LUNG) reported its Q1 earnings results on Tuesday, May 3, 2022 at 05:05 PM. Here's what investors need to know about the announcement. Earnings Pulmonx missed estimated earnings by...

Via Benzinga

Where Pulmonx Stands With Analysts ↗

February 25, 2022

Within the last quarter, Pulmonx (NASDAQ:LUNG) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

February 24, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 ↗

July 11, 2022

Upgrades

Via Benzinga

Global Stocks, Futures Crash; Nasdaq In Bear Market, Oil Soars Above $105 On Russia Attack ↗

February 24, 2022

U.S. stock index futures crashed along with global markets on Thursday as Russia’s assault on Ukraine sent investors fleeing risky assets, while the tech-heavy Nasdaq was set to open in a bear market.

Via Talk Markets

92 Biggest Movers From Friday ↗

May 09, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...

Via Benzinga

55 Stocks Moving In Friday's Mid-Day Session ↗

May 06, 2022

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗

December 08, 2021

Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...

Via Benzinga

Pulmonx Corporation (LUNG) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

LUNG earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Chief Financial Officer Of Pulmonx Makes $224.56 Thousand Sale ↗

September 22, 2021

Derrick Sung, Chief Financial Officer at Pulmonx (NASDAQ:LUNG), made a large insider sell on September 21, according to a new SEC filing. What Happened: A Form 4 filing from the U...

Via Benzinga

Topics Regulatory Compliance

Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment

September 21, 2021

From Pulmonx Corporation

Via Business Wire

3 Healthcare Stocks That Might Skyrocket When COVID Is Over ↗

September 07, 2021

Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over?

Via The Motley Fool

Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage for Severe COPD/Emphysema Treatment

August 20, 2021

From Pulmonx Corporation

Via Business Wire

Return on Capital Employed Overview: Pulmonx ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, Pulmonx (NASDAQ:LUNG) brought in sales totaling $12.20 million. However, earnings decreased 0.58%, resulting in a...

Via Benzinga

Pulmonx Corporation (LUNG) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

LUNG earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.